Familial Inclusion Body Myositis (FIBM)
Update
DOI:
https://doi.org/10.34024/rnc.2009.v17.8579Keywords:
Myositis, Inclusion Bodies, Neuromuscular DiseasesAbstract
Familial inclusion body myositis (FIBM) is extremely rare. The disease is characterized by relatively late onset, selective and early involvement of quadriceps, forearm and finger flexors, only mild increase of serum creatine kinase CK level, frequent rimmed vacuoles in muscle histopathology with substantial inflammatory cell infiltration. The combination of clinical, histological, immunopathological and immunogenetic features indicates that these patients have a disease identical to sporadic inclusion body myositis.
Downloads
References
Sivakumar K, Semino-Mora C, Dalakas MC. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis: Studies in three families. Brain 1997;120:653-61.
Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
Ranque-Francois B, Maisonobe T, Dion E, Piette JC, Chauveheid MP, Amoura Z, et al. Familial inflammatory inclusion body myositis. Ann Rheum Dis 2005;64:634-37.
Tateyama M, Saito N, Fujihara K, Shyga Y, Takeda A, Narikawa K, et al. Familial Inclusion Body Myositis: A Report on Two Japanese Sisters. Int Med 2003;42:1035-8.
Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 1995;7:486-96.
Hilton-Jones D. Diagnosis and treatment of inflammatory muscle diseases. J Neurol Neurosurg Psychiatr 2003; 74(Suppl II):ii25-31.
Mizusawa H. The familial occurrence may give a clue to the pathogenesis of inclusion body myositis. Int Med 2003;42:928-9.
Naumann M, Reichmann H, Goebel HH, Moll C, Toyka KV. Glucocorticoid-sensitive hereditary inclusion body myositis. J Neurol 1996;243:126-30.
Amato AA, Shebert RT. Inclusion body myositis in twins. Neurology 1998;51:598-600.
Hengstman GJ, van Engelen BG, ter Laak HJ, Gabreels-Festen AA. Familial inclusion body myositis with histologically confirmed sensorimotor axonal neuropathy. J Neurol 2000;247:882-4.
Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: Disease of oxidative stress and aging? Arch Neurol 1998;55:915-20.
Tawil R, Griggs RC. Inclusion body myositis. Curr Opin in Rheumatol 2002;14:653-7.
Dalakas MC. Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437-47.
Askanas VA, Engel WK. New advances in inclusion-body myositis. Curr Opin Rheumatol 1993;5:732-41.
Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001;29:83-7.
Argov Z, Eisenberg I, Mitrani-Rosenbaum S. Genetics of inclusion body myopathies. Curr Opin Rheumatol 1998;10:543-7.
Askanas V, Engel WK. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol 2001;60:1-14.
Fyhr IM, Moslemi AR, Mosavi AA, Lindberg C, Tarkowski A, Oldfors A. Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol 1997;9:185-9.
Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 1998;84:139-42.
Garlepp MJ, Laing B, Zilko PJ, Oilier W, Mastaglia FL. HLA associations with inclusion body myositis. Clin Exp Immunol 1994;98:40-5.
Sivakumar K, Dalakas MC. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology 1996;47:977-84.
Português
English
Español
